Stoke Therapeutics (STOK) Interest & Investment Income: 2022-2025
Historic Interest & Investment Income for Stoke Therapeutics (STOK) over the last 4 years, with Sep 2025 value amounting to $3.5 million.
- Stoke Therapeutics' Interest & Investment Income fell 2.31% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.1 million, marking a year-over-year increase of 7.00%. This contributed to the annual value of $12.6 million for FY2024, which is 27.55% up from last year.
- As of Q3 2025, Stoke Therapeutics' Interest & Investment Income stood at $3.5 million, which was down 8.60% from $3.8 million recorded in Q2 2025.
- Stoke Therapeutics' Interest & Investment Income's 5-year high stood at $3.8 million during Q2 2025, with a 5-year trough of $104,000 in Q1 2022.
- For the 3-year period, Stoke Therapeutics' Interest & Investment Income averaged around $3.0 million, with its median value being $2.9 million (2025).
- In the last 5 years, Stoke Therapeutics' Interest & Investment Income spiked by 1,922.12% in 2023 and then decreased by 2.31% in 2025.
- Stoke Therapeutics' Interest & Investment Income (Quarterly) stood at $1.5 million in 2022, then skyrocketed by 74.92% to $2.6 million in 2023, then grew by 14.80% to $3.0 million in 2024, then declined by 2.31% to $3.5 million in 2025.
- Its Interest & Investment Income was $3.5 million in Q3 2025, compared to $3.8 million in Q2 2025 and $2.9 million in Q1 2025.